Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Rhopressa netarsudil fda approval date?Brimonidine tartrate?How much does cefdinir cost without insurance?Generic for corlanor?Gemfibrozil 600 mg tab?
See the DrugPatentWatch profile for Loperamide
Loperamide is an antidiarrheal medication [1]. It belongs to the class of drugs known as opioid receptor agonists, though it is primarily designed to act on opioid receptors in the gut rather than the central nervous system [2].
Loperamide works by binding to mu-opioid receptors in the myenteric plexus of the large intestine [2]. This action slows down intestinal motility, allowing more time for water and electrolytes to be absorbed from the stool, thereby reducing the frequency and urgency of bowel movements [2][3]. It does not typically produce the central nervous system effects associated with other opioid agonists when used at recommended doses [2].
Loperamide is classified as a peripheral opioid receptor agonist [2]. While other drugs act on opioid receptors, loperamide's pharmacological profile is distinct due to its limited ability to cross the blood-brain barrier at therapeutic doses [2]. Examples of other opioid receptor agonists include codeine and morphine, which have significant central nervous system effects [4].
Information on specific patent expiry dates for loperamide is not readily available without access to specialized databases. DrugPatentWatch.com is a resource that tracks patent information for pharmaceuticals [5].
Loperamide is specifically indicated for the symptomatic treatment of acute and chronic diarrhea [1]. Its mechanism of action makes it effective for reducing the frequency of loose stools.
Other Questions About Loperamide :